Nexomics Biosciences

Nexomics Biosciences focuses on the discovery, development and commercialization of novel drugs focusing on cancer, antiviral and antibiotic treatments. Nexomics Biosciences also functions as a contract research organization (CRO), offering a broad array of gene-to-structure services to the biopharmaceutical community. We offer a variety of services from bioinformatics target profiling, gene cloning, recombinant protein expression, laboratory-scale fermentation, crystallization, NMR structural studies, X-ray crystallography structural studies, assay development, and functional annotation. Nexomics Biosciences aims to build a portfolio of intellectual property associated with structure-based assay development, protein production, and drug discovery. Our long term goal is development of a proprietary pharmaceutical...

Biotechnology,protein production,protein nmr,and xray crystallography

Nexomics biosciences operates in the Biotechnology industry.

Nexomics biosciences's revenue is 11m - 100m

Nexomics biosciences has 11 - 50 employees.